nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—CA9—hematologic cancer	0.285	1	CbGaD
Hydroflumethiazide—CA14—Imatinib—hematologic cancer	0.0531	0.109	CbGbCtD
Hydroflumethiazide—CA14—Nilotinib—hematologic cancer	0.0483	0.0995	CbGbCtD
Hydroflumethiazide—CA7—Imatinib—hematologic cancer	0.044	0.0906	CbGbCtD
Hydroflumethiazide—CA7—Nilotinib—hematologic cancer	0.04	0.0823	CbGbCtD
Hydroflumethiazide—CA9—Imatinib—hematologic cancer	0.0377	0.0778	CbGbCtD
Hydroflumethiazide—CA12—Imatinib—hematologic cancer	0.0377	0.0778	CbGbCtD
Hydroflumethiazide—CA1—Imatinib—hematologic cancer	0.0353	0.0727	CbGbCtD
Hydroflumethiazide—CA9—Nilotinib—hematologic cancer	0.0343	0.0707	CbGbCtD
Hydroflumethiazide—CA12—Nilotinib—hematologic cancer	0.0343	0.0707	CbGbCtD
Hydroflumethiazide—CA1—Nilotinib—hematologic cancer	0.0321	0.0661	CbGbCtD
Hydroflumethiazide—CA2—Imatinib—hematologic cancer	0.0305	0.0629	CbGbCtD
Hydroflumethiazide—CA4—Nilotinib—hematologic cancer	0.0302	0.0622	CbGbCtD
Hydroflumethiazide—CA2—Nilotinib—hematologic cancer	0.0277	0.0571	CbGbCtD
Hydroflumethiazide—SLC12A1—hematopoietic system—hematologic cancer	0.0016	0.0546	CbGeAlD
Hydroflumethiazide—KCNMA1—hematopoietic system—hematologic cancer	0.00145	0.0494	CbGeAlD
Hydroflumethiazide—CA5B—hematopoietic system—hematologic cancer	0.00125	0.0425	CbGeAlD
Hydroflumethiazide—SLC12A3—lung—hematologic cancer	0.00122	0.0415	CbGeAlD
Hydroflumethiazide—KCNMA1—gonad—hematologic cancer	0.0011	0.0376	CbGeAlD
Hydroflumethiazide—CA1—hematopoietic system—hematologic cancer	0.0011	0.0375	CbGeAlD
Hydroflumethiazide—SLC12A1—blood—hematologic cancer	0.00106	0.0361	CbGeAlD
Hydroflumethiazide—CA9—testis—hematologic cancer	0.00103	0.0351	CbGeAlD
Hydroflumethiazide—CA5B—gonad—hematologic cancer	0.000947	0.0323	CbGeAlD
Hydroflumethiazide—ATP1A1—hematopoietic system—hematologic cancer	0.00093	0.0318	CbGeAlD
Hydroflumethiazide—SLC12A1—testis—hematologic cancer	0.000876	0.0299	CbGeAlD
Hydroflumethiazide—KCNMA1—lung—hematologic cancer	0.000841	0.0287	CbGeAlD
Hydroflumethiazide—CA5B—blood—hematologic cancer	0.000825	0.0282	CbGeAlD
Hydroflumethiazide—CA12—lung—hematologic cancer	0.000806	0.0275	CbGeAlD
Hydroflumethiazide—KCNMA1—testis—hematologic cancer	0.000793	0.0271	CbGeAlD
Hydroflumethiazide—CA1—blood—hematologic cancer	0.000728	0.0249	CbGeAlD
Hydroflumethiazide—CA5B—lung—hematologic cancer	0.000723	0.0247	CbGeAlD
Hydroflumethiazide—CA2—hematopoietic system—hematologic cancer	0.000713	0.0243	CbGeAlD
Hydroflumethiazide—ATP1A1—gonad—hematologic cancer	0.000707	0.0241	CbGeAlD
Hydroflumethiazide—CA1—bone marrow—hematologic cancer	0.000705	0.0241	CbGeAlD
Hydroflumethiazide—CA5B—testis—hematologic cancer	0.000682	0.0233	CbGeAlD
Hydroflumethiazide—CA1—lung—hematologic cancer	0.000639	0.0218	CbGeAlD
Hydroflumethiazide—ATP1A1—blood—hematologic cancer	0.000616	0.021	CbGeAlD
Hydroflumethiazide—ATP1A1—bone marrow—hematologic cancer	0.000596	0.0204	CbGeAlD
Hydroflumethiazide—KCNMA1—lymph node—hematologic cancer	0.000575	0.0196	CbGeAlD
Hydroflumethiazide—CA4—blood—hematologic cancer	0.000569	0.0194	CbGeAlD
Hydroflumethiazide—CA4—bone marrow—hematologic cancer	0.000551	0.0188	CbGeAlD
Hydroflumethiazide—ATP1A1—lung—hematologic cancer	0.00054	0.0184	CbGeAlD
Hydroflumethiazide—ATP1A1—testis—hematologic cancer	0.00051	0.0174	CbGeAlD
Hydroflumethiazide—CA4—lung—hematologic cancer	0.000499	0.017	CbGeAlD
Hydroflumethiazide—CA5B—lymph node—hematologic cancer	0.000495	0.0169	CbGeAlD
Hydroflumethiazide—CA2—blood—hematologic cancer	0.000472	0.0161	CbGeAlD
Hydroflumethiazide—CA4—testis—hematologic cancer	0.000471	0.0161	CbGeAlD
Hydroflumethiazide—CA2—bone marrow—hematologic cancer	0.000457	0.0156	CbGeAlD
Hydroflumethiazide—Hydrochlorothiazide—CA9—hematologic cancer	0.000444	0.529	CrCbGaD
Hydroflumethiazide—CA1—lymph node—hematologic cancer	0.000437	0.0149	CbGeAlD
Hydroflumethiazide—CA2—lung—hematologic cancer	0.000414	0.0141	CbGeAlD
Hydroflumethiazide—Trichlormethiazide—CA9—hematologic cancer	0.000396	0.471	CrCbGaD
Hydroflumethiazide—CA2—testis—hematologic cancer	0.000391	0.0133	CbGeAlD
Hydroflumethiazide—ATP1A1—lymph node—hematologic cancer	0.000369	0.0126	CbGeAlD
Hydroflumethiazide—CA4—lymph node—hematologic cancer	0.000341	0.0117	CbGeAlD
Hydroflumethiazide—CA2—lymph node—hematologic cancer	0.000283	0.00966	CbGeAlD
Hydroflumethiazide—Decreased appetite—Gemcitabine—hematologic cancer	8.08e-05	0.000587	CcSEcCtD
Hydroflumethiazide—Urticaria—Alitretinoin—hematologic cancer	8.08e-05	0.000587	CcSEcCtD
Hydroflumethiazide—Vomiting—Hydroxyurea—hematologic cancer	8.07e-05	0.000586	CcSEcCtD
Hydroflumethiazide—Headache—Lenalidomide—hematologic cancer	8.07e-05	0.000586	CcSEcCtD
Hydroflumethiazide—Rash—Hydroxyurea—hematologic cancer	8.01e-05	0.000582	CcSEcCtD
Hydroflumethiazide—Dermatitis—Hydroxyurea—hematologic cancer	8e-05	0.000581	CcSEcCtD
Hydroflumethiazide—Urticaria—Ifosfamide—hematologic cancer	7.98e-05	0.00058	CcSEcCtD
Hydroflumethiazide—Headache—Hydroxyurea—hematologic cancer	7.96e-05	0.000578	CcSEcCtD
Hydroflumethiazide—Constipation—Gemcitabine—hematologic cancer	7.95e-05	0.000577	CcSEcCtD
Hydroflumethiazide—Asthenia—Thiotepa—hematologic cancer	7.93e-05	0.000576	CcSEcCtD
Hydroflumethiazide—Vertigo—Triamcinolone—hematologic cancer	7.93e-05	0.000576	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Vinorelbine—hematologic cancer	7.92e-05	0.000575	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Thalidomide—hematologic cancer	7.87e-05	0.000572	CcSEcCtD
Hydroflumethiazide—Nausea—Melphalan—hematologic cancer	7.87e-05	0.000571	CcSEcCtD
Hydroflumethiazide—Dizziness—Bortezomib—hematologic cancer	7.84e-05	0.000569	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Etoposide—hematologic cancer	7.77e-05	0.000565	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Epirubicin—hematologic cancer	7.67e-05	0.000557	CcSEcCtD
Hydroflumethiazide—Asthenia—Thalidomide—hematologic cancer	7.67e-05	0.000557	CcSEcCtD
Hydroflumethiazide—Dizziness—Vinorelbine—hematologic cancer	7.65e-05	0.000556	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Doxorubicin—hematologic cancer	7.65e-05	0.000556	CcSEcCtD
Hydroflumethiazide—Nausea—Lenalidomide—hematologic cancer	7.65e-05	0.000556	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Methotrexate—hematologic cancer	7.63e-05	0.000554	CcSEcCtD
Hydroflumethiazide—Urticaria—Mitoxantrone—hematologic cancer	7.58e-05	0.000551	CcSEcCtD
Hydroflumethiazide—Anorexia—Etoposide—hematologic cancer	7.57e-05	0.00055	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Carmustine—hematologic cancer	7.56e-05	0.000549	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Thiotepa—hematologic cancer	7.56e-05	0.000549	CcSEcCtD
Hydroflumethiazide—Nausea—Hydroxyurea—hematologic cancer	7.54e-05	0.000548	CcSEcCtD
Hydroflumethiazide—Vomiting—Bortezomib—hematologic cancer	7.54e-05	0.000547	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Cisplatin—hematologic cancer	7.53e-05	0.000547	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Alitretinoin—hematologic cancer	7.49e-05	0.000544	CcSEcCtD
Hydroflumethiazide—Vomiting—Bleomycin—hematologic cancer	7.48e-05	0.000543	CcSEcCtD
Hydroflumethiazide—Rash—Bortezomib—hematologic cancer	7.47e-05	0.000543	CcSEcCtD
Hydroflumethiazide—Dermatitis—Bortezomib—hematologic cancer	7.47e-05	0.000542	CcSEcCtD
Hydroflumethiazide—Headache—Bortezomib—hematologic cancer	7.42e-05	0.000539	CcSEcCtD
Hydroflumethiazide—Rash—Bleomycin—hematologic cancer	7.42e-05	0.000539	CcSEcCtD
Hydroflumethiazide—Dermatitis—Bleomycin—hematologic cancer	7.41e-05	0.000538	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Ifosfamide—hematologic cancer	7.4e-05	0.000538	CcSEcCtD
Hydroflumethiazide—Asthenia—Carmustine—hematologic cancer	7.37e-05	0.000535	CcSEcCtD
Hydroflumethiazide—Vomiting—Vinorelbine—hematologic cancer	7.36e-05	0.000534	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Thalidomide—hematologic cancer	7.31e-05	0.000531	CcSEcCtD
Hydroflumethiazide—Dizziness—Thiotepa—hematologic cancer	7.31e-05	0.000531	CcSEcCtD
Hydroflumethiazide—Asthenia—Alitretinoin—hematologic cancer	7.3e-05	0.00053	CcSEcCtD
Hydroflumethiazide—Rash—Vinorelbine—hematologic cancer	7.3e-05	0.00053	CcSEcCtD
Hydroflumethiazide—Dermatitis—Vinorelbine—hematologic cancer	7.29e-05	0.000529	CcSEcCtD
Hydroflumethiazide—Headache—Vinorelbine—hematologic cancer	7.25e-05	0.000527	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Vincristine—hematologic cancer	7.22e-05	0.000524	CcSEcCtD
Hydroflumethiazide—Asthenia—Ifosfamide—hematologic cancer	7.21e-05	0.000524	CcSEcCtD
Hydroflumethiazide—Vertigo—Betamethasone—hematologic cancer	7.19e-05	0.000522	CcSEcCtD
Hydroflumethiazide—Vertigo—Dexamethasone—hematologic cancer	7.19e-05	0.000522	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Epirubicin—hematologic cancer	7.14e-05	0.000519	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Doxorubicin—hematologic cancer	7.1e-05	0.000516	CcSEcCtD
Hydroflumethiazide—Dizziness—Thalidomide—hematologic cancer	7.07e-05	0.000513	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Epirubicin—hematologic cancer	7.06e-05	0.000513	CcSEcCtD
Hydroflumethiazide—Nausea—Bortezomib—hematologic cancer	7.04e-05	0.000511	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Mitoxantrone—hematologic cancer	7.03e-05	0.000511	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Irinotecan—hematologic cancer	7.03e-05	0.000511	CcSEcCtD
Hydroflumethiazide—Asthenia—Vincristine—hematologic cancer	7.03e-05	0.000511	CcSEcCtD
Hydroflumethiazide—Vomiting—Thiotepa—hematologic cancer	7.03e-05	0.00051	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Carmustine—hematologic cancer	7.02e-05	0.00051	CcSEcCtD
Hydroflumethiazide—Nausea—Bleomycin—hematologic cancer	6.99e-05	0.000507	CcSEcCtD
Hydroflumethiazide—Rash—Thiotepa—hematologic cancer	6.97e-05	0.000506	CcSEcCtD
Hydroflumethiazide—Dermatitis—Thiotepa—hematologic cancer	6.96e-05	0.000506	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Alitretinoin—hematologic cancer	6.96e-05	0.000505	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Methotrexate—hematologic cancer	6.96e-05	0.000505	CcSEcCtD
Hydroflumethiazide—Headache—Thiotepa—hematologic cancer	6.92e-05	0.000503	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Etoposide—hematologic cancer	6.9e-05	0.000501	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Ifosfamide—hematologic cancer	6.88e-05	0.0005	CcSEcCtD
Hydroflumethiazide—Nausea—Vinorelbine—hematologic cancer	6.87e-05	0.000499	CcSEcCtD
Hydroflumethiazide—Asthenia—Irinotecan—hematologic cancer	6.85e-05	0.000497	CcSEcCtD
Hydroflumethiazide—Asthenia—Mitoxantrone—hematologic cancer	6.85e-05	0.000497	CcSEcCtD
Hydroflumethiazide—Jaundice—Epirubicin—hematologic cancer	6.8e-05	0.000494	CcSEcCtD
Hydroflumethiazide—Vomiting—Thalidomide—hematologic cancer	6.8e-05	0.000494	CcSEcCtD
Hydroflumethiazide—Dizziness—Carmustine—hematologic cancer	6.79e-05	0.000493	CcSEcCtD
Hydroflumethiazide—Constipation—Etoposide—hematologic cancer	6.79e-05	0.000493	CcSEcCtD
Hydroflumethiazide—Rash—Thalidomide—hematologic cancer	6.74e-05	0.00049	CcSEcCtD
Hydroflumethiazide—Dermatitis—Thalidomide—hematologic cancer	6.73e-05	0.000489	CcSEcCtD
Hydroflumethiazide—Dizziness—Alitretinoin—hematologic cancer	6.72e-05	0.000488	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Vincristine—hematologic cancer	6.7e-05	0.000487	CcSEcCtD
Hydroflumethiazide—Headache—Thalidomide—hematologic cancer	6.7e-05	0.000486	CcSEcCtD
Hydroflumethiazide—Asthenia—Gemcitabine—hematologic cancer	6.67e-05	0.000484	CcSEcCtD
Hydroflumethiazide—Dizziness—Ifosfamide—hematologic cancer	6.65e-05	0.000483	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Doxorubicin—hematologic cancer	6.61e-05	0.00048	CcSEcCtD
Hydroflumethiazide—Nausea—Thiotepa—hematologic cancer	6.56e-05	0.000477	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Doxorubicin—hematologic cancer	6.53e-05	0.000474	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Mitoxantrone—hematologic cancer	6.53e-05	0.000474	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Irinotecan—hematologic cancer	6.53e-05	0.000474	CcSEcCtD
Hydroflumethiazide—Vomiting—Carmustine—hematologic cancer	6.53e-05	0.000474	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Epirubicin—hematologic cancer	6.51e-05	0.000473	CcSEcCtD
Hydroflumethiazide—Dizziness—Vincristine—hematologic cancer	6.48e-05	0.000471	CcSEcCtD
Hydroflumethiazide—Rash—Carmustine—hematologic cancer	6.47e-05	0.00047	CcSEcCtD
Hydroflumethiazide—Dermatitis—Carmustine—hematologic cancer	6.47e-05	0.00047	CcSEcCtD
Hydroflumethiazide—Vomiting—Alitretinoin—hematologic cancer	6.47e-05	0.00047	CcSEcCtD
Hydroflumethiazide—Headache—Carmustine—hematologic cancer	6.43e-05	0.000467	CcSEcCtD
Hydroflumethiazide—Rash—Alitretinoin—hematologic cancer	6.41e-05	0.000466	CcSEcCtD
Hydroflumethiazide—Agitation—Prednisone—hematologic cancer	6.41e-05	0.000465	CcSEcCtD
Hydroflumethiazide—Dermatitis—Alitretinoin—hematologic cancer	6.41e-05	0.000465	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Betamethasone—hematologic cancer	6.4e-05	0.000465	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Dexamethasone—hematologic cancer	6.4e-05	0.000465	CcSEcCtD
Hydroflumethiazide—Vomiting—Ifosfamide—hematologic cancer	6.39e-05	0.000464	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Cisplatin—hematologic cancer	6.38e-05	0.000464	CcSEcCtD
Hydroflumethiazide—Headache—Alitretinoin—hematologic cancer	6.37e-05	0.000463	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Gemcitabine—hematologic cancer	6.36e-05	0.000462	CcSEcCtD
Hydroflumethiazide—Nausea—Thalidomide—hematologic cancer	6.35e-05	0.000461	CcSEcCtD
Hydroflumethiazide—Rash—Ifosfamide—hematologic cancer	6.34e-05	0.00046	CcSEcCtD
Hydroflumethiazide—Dermatitis—Ifosfamide—hematologic cancer	6.33e-05	0.00046	CcSEcCtD
Hydroflumethiazide—Dizziness—Irinotecan—hematologic cancer	6.31e-05	0.000458	CcSEcCtD
Hydroflumethiazide—Urticaria—Etoposide—hematologic cancer	6.31e-05	0.000458	CcSEcCtD
Hydroflumethiazide—Jaundice—Doxorubicin—hematologic cancer	6.29e-05	0.000457	CcSEcCtD
Hydroflumethiazide—Vertigo—Prednisone—hematologic cancer	6.26e-05	0.000455	CcSEcCtD
Hydroflumethiazide—Vomiting—Vincristine—hematologic cancer	6.23e-05	0.000453	CcSEcCtD
Hydroflumethiazide—Anorexia—Betamethasone—hematologic cancer	6.23e-05	0.000452	CcSEcCtD
Hydroflumethiazide—Anorexia—Dexamethasone—hematologic cancer	6.23e-05	0.000452	CcSEcCtD
Hydroflumethiazide—Urticaria—Prednisolone—hematologic cancer	6.22e-05	0.000452	CcSEcCtD
Hydroflumethiazide—Asthenia—Cisplatin—hematologic cancer	6.22e-05	0.000452	CcSEcCtD
Hydroflumethiazide—Rash—Vincristine—hematologic cancer	6.18e-05	0.000449	CcSEcCtD
Hydroflumethiazide—Dermatitis—Vincristine—hematologic cancer	6.17e-05	0.000448	CcSEcCtD
Hydroflumethiazide—Headache—Vincristine—hematologic cancer	6.14e-05	0.000446	CcSEcCtD
Hydroflumethiazide—Nausea—Carmustine—hematologic cancer	6.1e-05	0.000443	CcSEcCtD
Hydroflumethiazide—Vomiting—Mitoxantrone—hematologic cancer	6.07e-05	0.000441	CcSEcCtD
Hydroflumethiazide—Vomiting—Irinotecan—hematologic cancer	6.07e-05	0.000441	CcSEcCtD
Hydroflumethiazide—Nausea—Alitretinoin—hematologic cancer	6.04e-05	0.000439	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Doxorubicin—hematologic cancer	6.02e-05	0.000438	CcSEcCtD
Hydroflumethiazide—Rash—Irinotecan—hematologic cancer	6.02e-05	0.000437	CcSEcCtD
Hydroflumethiazide—Rash—Mitoxantrone—hematologic cancer	6.02e-05	0.000437	CcSEcCtD
Hydroflumethiazide—Dermatitis—Irinotecan—hematologic cancer	6.01e-05	0.000437	CcSEcCtD
Hydroflumethiazide—Dermatitis—Mitoxantrone—hematologic cancer	6.01e-05	0.000437	CcSEcCtD
Hydroflumethiazide—Headache—Mitoxantrone—hematologic cancer	5.98e-05	0.000434	CcSEcCtD
Hydroflumethiazide—Headache—Irinotecan—hematologic cancer	5.98e-05	0.000434	CcSEcCtD
Hydroflumethiazide—Nausea—Ifosfamide—hematologic cancer	5.97e-05	0.000434	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Cisplatin—hematologic cancer	5.93e-05	0.000431	CcSEcCtD
Hydroflumethiazide—Vomiting—Gemcitabine—hematologic cancer	5.91e-05	0.000429	CcSEcCtD
Hydroflumethiazide—Rash—Gemcitabine—hematologic cancer	5.86e-05	0.000426	CcSEcCtD
Hydroflumethiazide—Dermatitis—Gemcitabine—hematologic cancer	5.86e-05	0.000425	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Etoposide—hematologic cancer	5.85e-05	0.000425	CcSEcCtD
Hydroflumethiazide—Headache—Gemcitabine—hematologic cancer	5.82e-05	0.000423	CcSEcCtD
Hydroflumethiazide—Nausea—Vincristine—hematologic cancer	5.82e-05	0.000423	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Prednisolone—hematologic cancer	5.77e-05	0.000419	CcSEcCtD
Hydroflumethiazide—Urticaria—Triamcinolone—hematologic cancer	5.72e-05	0.000415	CcSEcCtD
Hydroflumethiazide—Asthenia—Etoposide—hematologic cancer	5.7e-05	0.000414	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Betamethasone—hematologic cancer	5.68e-05	0.000413	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Dexamethasone—hematologic cancer	5.68e-05	0.000413	CcSEcCtD
Hydroflumethiazide—Nausea—Mitoxantrone—hematologic cancer	5.67e-05	0.000412	CcSEcCtD
Hydroflumethiazide—Nausea—Irinotecan—hematologic cancer	5.67e-05	0.000412	CcSEcCtD
Hydroflumethiazide—Nausea—Gemcitabine—hematologic cancer	5.52e-05	0.000401	CcSEcCtD
Hydroflumethiazide—Vomiting—Cisplatin—hematologic cancer	5.51e-05	0.0004	CcSEcCtD
Hydroflumethiazide—Rash—Cisplatin—hematologic cancer	5.46e-05	0.000397	CcSEcCtD
Hydroflumethiazide—Dermatitis—Cisplatin—hematologic cancer	5.46e-05	0.000396	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Etoposide—hematologic cancer	5.43e-05	0.000395	CcSEcCtD
Hydroflumethiazide—Anorexia—Prednisone—hematologic cancer	5.42e-05	0.000394	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Triamcinolone—hematologic cancer	5.3e-05	0.000385	CcSEcCtD
Hydroflumethiazide—Dizziness—Etoposide—hematologic cancer	5.25e-05	0.000381	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Epirubicin—hematologic cancer	5.24e-05	0.000381	CcSEcCtD
Hydroflumethiazide—Vertigo—Methotrexate—hematologic cancer	5.23e-05	0.00038	CcSEcCtD
Hydroflumethiazide—Leukopenia—Methotrexate—hematologic cancer	5.21e-05	0.000379	CcSEcCtD
Hydroflumethiazide—Urticaria—Dexamethasone—hematologic cancer	5.19e-05	0.000377	CcSEcCtD
Hydroflumethiazide—Urticaria—Betamethasone—hematologic cancer	5.19e-05	0.000377	CcSEcCtD
Hydroflumethiazide—Dizziness—Prednisolone—hematologic cancer	5.18e-05	0.000376	CcSEcCtD
Hydroflumethiazide—Asthenia—Triamcinolone—hematologic cancer	5.17e-05	0.000375	CcSEcCtD
Hydroflumethiazide—Nausea—Cisplatin—hematologic cancer	5.15e-05	0.000374	CcSEcCtD
Hydroflumethiazide—Vomiting—Etoposide—hematologic cancer	5.05e-05	0.000367	CcSEcCtD
Hydroflumethiazide—Agitation—Epirubicin—hematologic cancer	5.01e-05	0.000364	CcSEcCtD
Hydroflumethiazide—Rash—Etoposide—hematologic cancer	5.01e-05	0.000364	CcSEcCtD
Hydroflumethiazide—Dermatitis—Etoposide—hematologic cancer	5e-05	0.000363	CcSEcCtD
Hydroflumethiazide—Headache—Etoposide—hematologic cancer	4.97e-05	0.000361	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Prednisone—hematologic cancer	4.95e-05	0.000359	CcSEcCtD
Hydroflumethiazide—Rash—Prednisolone—hematologic cancer	4.94e-05	0.000359	CcSEcCtD
Hydroflumethiazide—Dermatitis—Prednisolone—hematologic cancer	4.93e-05	0.000358	CcSEcCtD
Hydroflumethiazide—Headache—Prednisolone—hematologic cancer	4.9e-05	0.000356	CcSEcCtD
Hydroflumethiazide—Vertigo—Epirubicin—hematologic cancer	4.9e-05	0.000356	CcSEcCtD
Hydroflumethiazide—Leukopenia—Epirubicin—hematologic cancer	4.88e-05	0.000354	CcSEcCtD
Hydroflumethiazide—Constipation—Prednisone—hematologic cancer	4.87e-05	0.000353	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Doxorubicin—hematologic cancer	4.85e-05	0.000352	CcSEcCtD
Hydroflumethiazide—Dizziness—Triamcinolone—hematologic cancer	4.76e-05	0.000346	CcSEcCtD
Hydroflumethiazide—Nausea—Etoposide—hematologic cancer	4.72e-05	0.000342	CcSEcCtD
Hydroflumethiazide—Asthenia—Dexamethasone—hematologic cancer	4.69e-05	0.00034	CcSEcCtD
Hydroflumethiazide—Asthenia—Betamethasone—hematologic cancer	4.69e-05	0.00034	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Methotrexate—hematologic cancer	4.66e-05	0.000338	CcSEcCtD
Hydroflumethiazide—Nausea—Prednisolone—hematologic cancer	4.65e-05	0.000338	CcSEcCtD
Hydroflumethiazide—Agitation—Doxorubicin—hematologic cancer	4.64e-05	0.000337	CcSEcCtD
Hydroflumethiazide—Vomiting—Triamcinolone—hematologic cancer	4.58e-05	0.000333	CcSEcCtD
Hydroflumethiazide—Rash—Triamcinolone—hematologic cancer	4.54e-05	0.00033	CcSEcCtD
Hydroflumethiazide—Dermatitis—Triamcinolone—hematologic cancer	4.54e-05	0.000329	CcSEcCtD
Hydroflumethiazide—Vertigo—Doxorubicin—hematologic cancer	4.53e-05	0.000329	CcSEcCtD
Hydroflumethiazide—Anorexia—Methotrexate—hematologic cancer	4.53e-05	0.000329	CcSEcCtD
Hydroflumethiazide—Urticaria—Prednisone—hematologic cancer	4.52e-05	0.000328	CcSEcCtD
Hydroflumethiazide—Leukopenia—Doxorubicin—hematologic cancer	4.52e-05	0.000328	CcSEcCtD
Hydroflumethiazide—Headache—Triamcinolone—hematologic cancer	4.51e-05	0.000328	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Dexamethasone—hematologic cancer	4.47e-05	0.000325	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Betamethasone—hematologic cancer	4.47e-05	0.000325	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Epirubicin—hematologic cancer	4.36e-05	0.000316	CcSEcCtD
Hydroflumethiazide—Dizziness—Dexamethasone—hematologic cancer	4.32e-05	0.000314	CcSEcCtD
Hydroflumethiazide—Dizziness—Betamethasone—hematologic cancer	4.32e-05	0.000314	CcSEcCtD
Hydroflumethiazide—Nausea—Triamcinolone—hematologic cancer	4.28e-05	0.000311	CcSEcCtD
Hydroflumethiazide—Anorexia—Epirubicin—hematologic cancer	4.24e-05	0.000308	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Prednisone—hematologic cancer	4.19e-05	0.000304	CcSEcCtD
Hydroflumethiazide—Vomiting—Dexamethasone—hematologic cancer	4.15e-05	0.000302	CcSEcCtD
Hydroflumethiazide—Vomiting—Betamethasone—hematologic cancer	4.15e-05	0.000302	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Methotrexate—hematologic cancer	4.13e-05	0.0003	CcSEcCtD
Hydroflumethiazide—Rash—Dexamethasone—hematologic cancer	4.12e-05	0.000299	CcSEcCtD
Hydroflumethiazide—Rash—Betamethasone—hematologic cancer	4.12e-05	0.000299	CcSEcCtD
Hydroflumethiazide—Dermatitis—Dexamethasone—hematologic cancer	4.12e-05	0.000299	CcSEcCtD
Hydroflumethiazide—Dermatitis—Betamethasone—hematologic cancer	4.12e-05	0.000299	CcSEcCtD
Hydroflumethiazide—Headache—Betamethasone—hematologic cancer	4.09e-05	0.000297	CcSEcCtD
Hydroflumethiazide—Headache—Dexamethasone—hematologic cancer	4.09e-05	0.000297	CcSEcCtD
Hydroflumethiazide—Asthenia—Prednisone—hematologic cancer	4.08e-05	0.000297	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Doxorubicin—hematologic cancer	4.03e-05	0.000293	CcSEcCtD
Hydroflumethiazide—Anorexia—Doxorubicin—hematologic cancer	3.92e-05	0.000285	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Prednisone—hematologic cancer	3.89e-05	0.000283	CcSEcCtD
Hydroflumethiazide—Nausea—Dexamethasone—hematologic cancer	3.88e-05	0.000282	CcSEcCtD
Hydroflumethiazide—Nausea—Betamethasone—hematologic cancer	3.88e-05	0.000282	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Epirubicin—hematologic cancer	3.87e-05	0.000281	CcSEcCtD
Hydroflumethiazide—Constipation—Epirubicin—hematologic cancer	3.81e-05	0.000276	CcSEcCtD
Hydroflumethiazide—Urticaria—Methotrexate—hematologic cancer	3.78e-05	0.000274	CcSEcCtD
Hydroflumethiazide—Dizziness—Prednisone—hematologic cancer	3.76e-05	0.000273	CcSEcCtD
Hydroflumethiazide—Vomiting—Prednisone—hematologic cancer	3.62e-05	0.000263	CcSEcCtD
Hydroflumethiazide—Rash—Prednisone—hematologic cancer	3.59e-05	0.000261	CcSEcCtD
Hydroflumethiazide—Dermatitis—Prednisone—hematologic cancer	3.58e-05	0.00026	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Doxorubicin—hematologic cancer	3.58e-05	0.00026	CcSEcCtD
Hydroflumethiazide—Headache—Prednisone—hematologic cancer	3.56e-05	0.000259	CcSEcCtD
Hydroflumethiazide—Urticaria—Epirubicin—hematologic cancer	3.53e-05	0.000257	CcSEcCtD
Hydroflumethiazide—Constipation—Doxorubicin—hematologic cancer	3.52e-05	0.000256	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Methotrexate—hematologic cancer	3.5e-05	0.000254	CcSEcCtD
Hydroflumethiazide—Asthenia—Methotrexate—hematologic cancer	3.41e-05	0.000248	CcSEcCtD
Hydroflumethiazide—Nausea—Prednisone—hematologic cancer	3.38e-05	0.000245	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Epirubicin—hematologic cancer	3.28e-05	0.000238	CcSEcCtD
Hydroflumethiazide—Urticaria—Doxorubicin—hematologic cancer	3.27e-05	0.000238	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Methotrexate—hematologic cancer	3.25e-05	0.000236	CcSEcCtD
Hydroflumethiazide—Asthenia—Epirubicin—hematologic cancer	3.19e-05	0.000232	CcSEcCtD
Hydroflumethiazide—Dizziness—Methotrexate—hematologic cancer	3.14e-05	0.000228	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Epirubicin—hematologic cancer	3.04e-05	0.000221	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Doxorubicin—hematologic cancer	3.03e-05	0.00022	CcSEcCtD
Hydroflumethiazide—Vomiting—Methotrexate—hematologic cancer	3.02e-05	0.00022	CcSEcCtD
Hydroflumethiazide—Rash—Methotrexate—hematologic cancer	3e-05	0.000218	CcSEcCtD
Hydroflumethiazide—Dermatitis—Methotrexate—hematologic cancer	3e-05	0.000218	CcSEcCtD
Hydroflumethiazide—Headache—Methotrexate—hematologic cancer	2.98e-05	0.000216	CcSEcCtD
Hydroflumethiazide—Asthenia—Doxorubicin—hematologic cancer	2.95e-05	0.000215	CcSEcCtD
Hydroflumethiazide—Dizziness—Epirubicin—hematologic cancer	2.94e-05	0.000214	CcSEcCtD
Hydroflumethiazide—Vomiting—Epirubicin—hematologic cancer	2.83e-05	0.000206	CcSEcCtD
Hydroflumethiazide—Nausea—Methotrexate—hematologic cancer	2.82e-05	0.000205	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Doxorubicin—hematologic cancer	2.82e-05	0.000205	CcSEcCtD
Hydroflumethiazide—Rash—Epirubicin—hematologic cancer	2.81e-05	0.000204	CcSEcCtD
Hydroflumethiazide—Dermatitis—Epirubicin—hematologic cancer	2.8e-05	0.000204	CcSEcCtD
Hydroflumethiazide—Headache—Epirubicin—hematologic cancer	2.79e-05	0.000202	CcSEcCtD
Hydroflumethiazide—Dizziness—Doxorubicin—hematologic cancer	2.72e-05	0.000198	CcSEcCtD
Hydroflumethiazide—Nausea—Epirubicin—hematologic cancer	2.64e-05	0.000192	CcSEcCtD
Hydroflumethiazide—Vomiting—Doxorubicin—hematologic cancer	2.62e-05	0.00019	CcSEcCtD
Hydroflumethiazide—Rash—Doxorubicin—hematologic cancer	2.6e-05	0.000189	CcSEcCtD
Hydroflumethiazide—Dermatitis—Doxorubicin—hematologic cancer	2.59e-05	0.000188	CcSEcCtD
Hydroflumethiazide—Headache—Doxorubicin—hematologic cancer	2.58e-05	0.000187	CcSEcCtD
Hydroflumethiazide—Nausea—Doxorubicin—hematologic cancer	2.45e-05	0.000178	CcSEcCtD
Hydroflumethiazide—CA1—Metabolism—IDH1—hematologic cancer	2.26e-05	0.000365	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.25e-05	0.000364	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—CREBBP—hematologic cancer	2.24e-05	0.000362	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTO1—hematologic cancer	2.23e-05	0.000361	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ABCC3—hematologic cancer	2.23e-05	0.000361	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—TXN—hematologic cancer	2.23e-05	0.000361	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SLC22A1—hematologic cancer	2.22e-05	0.000359	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CRABP1—hematologic cancer	2.22e-05	0.000359	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CYCS—hematologic cancer	2.21e-05	0.000356	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—HSP90AA1—hematologic cancer	2.19e-05	0.000354	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—UGT1A1—hematologic cancer	2.19e-05	0.000354	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SPHK1—hematologic cancer	2.19e-05	0.000353	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ARNTL—hematologic cancer	2.17e-05	0.000351	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ALOX5—hematologic cancer	2.17e-05	0.00035	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CDKN1B—hematologic cancer	2.15e-05	0.000347	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SLC22A1—hematologic cancer	2.13e-05	0.000344	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CRABP1—hematologic cancer	2.13e-05	0.000344	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PIK3CD—hematologic cancer	2.12e-05	0.000343	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CD44—hematologic cancer	2.12e-05	0.000342	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CD44—hematologic cancer	2.12e-05	0.000342	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—NQO1—hematologic cancer	2.12e-05	0.000342	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—NQO1—hematologic cancer	2.12e-05	0.000342	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ACP5—hematologic cancer	2.11e-05	0.000341	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.11e-05	0.00034	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—UGT1A1—hematologic cancer	2.1e-05	0.000339	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NUP98—hematologic cancer	2.1e-05	0.000339	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—ALB—hematologic cancer	2.1e-05	0.000338	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—IL6—hematologic cancer	2.09e-05	0.000338	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NCOR2—hematologic cancer	2.09e-05	0.000337	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ALOX5—hematologic cancer	2.08e-05	0.000335	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—JUN—hematologic cancer	2.05e-05	0.00033	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.05e-05	0.00033	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.05e-05	0.00033	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SLC22A1—hematologic cancer	2.04e-05	0.00033	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CRABP1—hematologic cancer	2.04e-05	0.00033	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ADCY7—hematologic cancer	2.04e-05	0.000329	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NCOA3—hematologic cancer	2.04e-05	0.000329	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NUP214—hematologic cancer	2.02e-05	0.000326	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NUP98—hematologic cancer	2.01e-05	0.000325	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CYCS—hematologic cancer	2.01e-05	0.000324	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CYCS—hematologic cancer	2.01e-05	0.000324	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PIK3R1—hematologic cancer	2.01e-05	0.000324	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—HSP90AA1—hematologic cancer	1.99e-05	0.000322	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—HSP90AA1—hematologic cancer	1.99e-05	0.000322	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ALOX5—hematologic cancer	1.99e-05	0.000321	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—IDH1—hematologic cancer	1.99e-05	0.000321	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CDKN1A—hematologic cancer	1.98e-05	0.00032	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—MTR—hematologic cancer	1.98e-05	0.00032	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ABCG2—hematologic cancer	1.98e-05	0.00032	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—NQO1—hematologic cancer	1.96e-05	0.000317	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—TXN—hematologic cancer	1.96e-05	0.000317	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTO1—hematologic cancer	1.96e-05	0.000317	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ABCC3—hematologic cancer	1.96e-05	0.000317	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CD44—hematologic cancer	1.96e-05	0.000317	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ADCY7—hematologic cancer	1.95e-05	0.000315	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NCOA3—hematologic cancer	1.95e-05	0.000315	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—JAK2—hematologic cancer	1.95e-05	0.000315	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTP1—hematologic cancer	1.94e-05	0.000314	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ENO2—hematologic cancer	1.94e-05	0.000314	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NUP214—hematologic cancer	1.94e-05	0.000313	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—MAPK8—hematologic cancer	1.94e-05	0.000313	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NUP98—hematologic cancer	1.93e-05	0.000311	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SPHK1—hematologic cancer	1.92e-05	0.00031	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.91e-05	0.000309	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.91e-05	0.000309	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—MTR—hematologic cancer	1.9e-05	0.000307	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ABCG2—hematologic cancer	1.9e-05	0.000307	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—EP300—hematologic cancer	1.89e-05	0.000305	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTT1—hematologic cancer	1.88e-05	0.000304	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ADCY7—hematologic cancer	1.87e-05	0.000302	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NCOA3—hematologic cancer	1.87e-05	0.000302	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ENO2—hematologic cancer	1.86e-05	0.000301	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NUP214—hematologic cancer	1.86e-05	0.0003	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYCS—hematologic cancer	1.86e-05	0.0003	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PIK3CB—hematologic cancer	1.85e-05	0.000299	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—UGT1A1—hematologic cancer	1.85e-05	0.000298	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—HSP90AA1—hematologic cancer	1.85e-05	0.000298	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SDC1—hematologic cancer	1.84e-05	0.000297	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ABCB1—hematologic cancer	1.84e-05	0.000297	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ABCG2—hematologic cancer	1.82e-05	0.000294	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—MTR—hematologic cancer	1.82e-05	0.000294	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTT1—hematologic cancer	1.81e-05	0.000292	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC22A1—hematologic cancer	1.8e-05	0.00029	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CRABP1—hematologic cancer	1.8e-05	0.00029	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—VEGFA—hematologic cancer	1.79e-05	0.000289	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ENO2—hematologic cancer	1.79e-05	0.000288	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTM1—hematologic cancer	1.79e-05	0.000288	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—NCOR1—hematologic cancer	1.79e-05	0.000288	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—STAT3—hematologic cancer	1.77e-05	0.000286	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTP1—hematologic cancer	1.77e-05	0.000285	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTP1—hematologic cancer	1.77e-05	0.000285	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SDC1—hematologic cancer	1.77e-05	0.000285	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALOX5—hematologic cancer	1.75e-05	0.000283	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTT1—hematologic cancer	1.73e-05	0.00028	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IL2—hematologic cancer	1.7e-05	0.000274	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NUP98—hematologic cancer	1.7e-05	0.000274	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SDC1—hematologic cancer	1.69e-05	0.000273	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—MAPK3—hematologic cancer	1.69e-05	0.000273	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—HRAS—hematologic cancer	1.68e-05	0.000271	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ABCB1—hematologic cancer	1.67e-05	0.00027	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ABCB1—hematologic cancer	1.67e-05	0.00027	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ADCY7—hematologic cancer	1.65e-05	0.000266	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NCOA3—hematologic cancer	1.65e-05	0.000266	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTP1—hematologic cancer	1.64e-05	0.000264	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NUP214—hematologic cancer	1.63e-05	0.000264	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—NCOR1—hematologic cancer	1.63e-05	0.000262	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTM1—hematologic cancer	1.63e-05	0.000262	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTM1—hematologic cancer	1.63e-05	0.000262	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—NCOR1—hematologic cancer	1.63e-05	0.000262	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ABCG2—hematologic cancer	1.6e-05	0.000258	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—MTR—hematologic cancer	1.6e-05	0.000258	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—MTHFR—hematologic cancer	1.58e-05	0.000255	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ENO2—hematologic cancer	1.57e-05	0.000253	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CD44—hematologic cancer	1.57e-05	0.000253	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NQO1—hematologic cancer	1.57e-05	0.000253	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ABCB1—hematologic cancer	1.55e-05	0.00025	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—EP300—hematologic cancer	1.53e-05	0.000246	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTT1—hematologic cancer	1.52e-05	0.000246	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—NCOR1—hematologic cancer	1.51e-05	0.000243	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTM1—hematologic cancer	1.51e-05	0.000243	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CD44—hematologic cancer	1.5e-05	0.000242	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NQO1—hematologic cancer	1.5e-05	0.000242	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SDC1—hematologic cancer	1.49e-05	0.00024	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—SRC—hematologic cancer	1.48e-05	0.000239	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYCS—hematologic cancer	1.48e-05	0.000239	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—HSP90AA1—hematologic cancer	1.47e-05	0.000238	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—VEGFA—hematologic cancer	1.44e-05	0.000233	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NQO1—hematologic cancer	1.44e-05	0.000232	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CD44—hematologic cancer	1.44e-05	0.000232	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—MTHFR—hematologic cancer	1.44e-05	0.000232	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—MTHFR—hematologic cancer	1.44e-05	0.000232	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—NRAS—hematologic cancer	1.43e-05	0.00023	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYCS—hematologic cancer	1.42e-05	0.000229	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—HSP90AA1—hematologic cancer	1.41e-05	0.000228	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—MAPK3—hematologic cancer	1.37e-05	0.000221	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYCS—hematologic cancer	1.36e-05	0.00022	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—HSP90AA1—hematologic cancer	1.35e-05	0.000218	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—TP53—hematologic cancer	1.35e-05	0.000218	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—MTHFR—hematologic cancer	1.33e-05	0.000215	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CG—hematologic cancer	1.33e-05	0.000214	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TGFB1—hematologic cancer	1.33e-05	0.000214	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTP1—hematologic cancer	1.31e-05	0.000211	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CD44—hematologic cancer	1.27e-05	0.000204	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NQO1—hematologic cancer	1.27e-05	0.000204	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTP1—hematologic cancer	1.25e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—IL6—hematologic cancer	1.24e-05	0.0002	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ABCB1—hematologic cancer	1.24e-05	0.0002	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CREBBP—hematologic cancer	1.23e-05	0.000198	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—KRAS—hematologic cancer	1.23e-05	0.000198	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CG—hematologic cancer	1.21e-05	0.000195	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CG—hematologic cancer	1.21e-05	0.000195	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTP1—hematologic cancer	1.2e-05	0.000194	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NCOR1—hematologic cancer	1.2e-05	0.000194	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTM1—hematologic cancer	1.2e-05	0.000194	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYCS—hematologic cancer	1.2e-05	0.000193	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HSP90AA1—hematologic cancer	1.19e-05	0.000192	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ABCB1—hematologic cancer	1.19e-05	0.000191	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CD—hematologic cancer	1.17e-05	0.000188	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTM1—hematologic cancer	1.15e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NCOR1—hematologic cancer	1.15e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ALB—hematologic cancer	1.15e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ABCB1—hematologic cancer	1.14e-05	0.000183	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PIK3CA—hematologic cancer	1.13e-05	0.000182	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CREBBP—hematologic cancer	1.12e-05	0.000181	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CREBBP—hematologic cancer	1.12e-05	0.000181	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CG—hematologic cancer	1.12e-05	0.00018	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NCOR1—hematologic cancer	1.1e-05	0.000178	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTM1—hematologic cancer	1.1e-05	0.000178	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3R1—hematologic cancer	1.1e-05	0.000178	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TP53—hematologic cancer	1.09e-05	0.000176	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—MTHFR—hematologic cancer	1.06e-05	0.000171	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CD—hematologic cancer	1.06e-05	0.000171	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CD—hematologic cancer	1.06e-05	0.000171	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTP1—hematologic cancer	1.06e-05	0.00017	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ALB—hematologic cancer	1.05e-05	0.000169	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ALB—hematologic cancer	1.05e-05	0.000169	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—HRAS—hematologic cancer	1.04e-05	0.000169	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CREBBP—hematologic cancer	1.04e-05	0.000167	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—MTHFR—hematologic cancer	1.02e-05	0.000164	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CB—hematologic cancer	1.02e-05	0.000164	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3R1—hematologic cancer	1e-05	0.000162	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3R1—hematologic cancer	1e-05	0.000162	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ABCB1—hematologic cancer	9.99e-06	0.000161	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CD—hematologic cancer	9.83e-06	0.000159	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—MTHFR—hematologic cancer	9.75e-06	0.000157	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NCOR1—hematologic cancer	9.7e-06	0.000157	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTM1—hematologic cancer	9.7e-06	0.000157	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ALB—hematologic cancer	9.7e-06	0.000157	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3R1—hematologic cancer	9.28e-06	0.00015	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CB—hematologic cancer	9.25e-06	0.000149	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CB—hematologic cancer	9.25e-06	0.000149	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—AKT1—hematologic cancer	9.22e-06	0.000149	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CG—hematologic cancer	8.91e-06	0.000144	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTEN—hematologic cancer	8.78e-06	0.000142	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—MTHFR—hematologic cancer	8.57e-06	0.000138	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CB—hematologic cancer	8.57e-06	0.000138	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CG—hematologic cancer	8.55e-06	0.000138	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—EP300—hematologic cancer	8.37e-06	0.000135	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CREBBP—hematologic cancer	8.27e-06	0.000133	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CG—hematologic cancer	8.19e-06	0.000132	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTEN—hematologic cancer	7.99e-06	0.000129	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTEN—hematologic cancer	7.99e-06	0.000129	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CREBBP—hematologic cancer	7.92e-06	0.000128	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CD—hematologic cancer	7.84e-06	0.000126	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ALB—hematologic cancer	7.74e-06	0.000125	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—EP300—hematologic cancer	7.62e-06	0.000123	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—EP300—hematologic cancer	7.62e-06	0.000123	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CREBBP—hematologic cancer	7.6e-06	0.000123	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CD—hematologic cancer	7.51e-06	0.000121	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ALB—hematologic cancer	7.42e-06	0.00012	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTEN—hematologic cancer	7.4e-06	0.000119	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3R1—hematologic cancer	7.4e-06	0.000119	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CG—hematologic cancer	7.2e-06	0.000116	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CD—hematologic cancer	7.2e-06	0.000116	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ALB—hematologic cancer	7.11e-06	0.000115	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3R1—hematologic cancer	7.09e-06	0.000115	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—EP300—hematologic cancer	7.06e-06	0.000114	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CB—hematologic cancer	6.83e-06	0.00011	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3R1—hematologic cancer	6.8e-06	0.00011	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CREBBP—hematologic cancer	6.68e-06	0.000108	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CB—hematologic cancer	6.55e-06	0.000106	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CD—hematologic cancer	6.33e-06	0.000102	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CB—hematologic cancer	6.28e-06	0.000101	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALB—hematologic cancer	6.25e-06	0.000101	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CA—hematologic cancer	6.2e-06	0.0001	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3R1—hematologic cancer	5.98e-06	9.65e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTEN—hematologic cancer	5.9e-06	9.53e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTEN—hematologic cancer	5.66e-06	9.13e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CA—hematologic cancer	5.64e-06	9.1e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CA—hematologic cancer	5.64e-06	9.1e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—EP300—hematologic cancer	5.63e-06	9.09e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CB—hematologic cancer	5.52e-06	8.91e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTEN—hematologic cancer	5.43e-06	8.76e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—EP300—hematologic cancer	5.4e-06	8.71e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CA—hematologic cancer	5.22e-06	8.43e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—EP300—hematologic cancer	5.17e-06	8.35e-05	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—AKT1—hematologic cancer	5.06e-06	8.17e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTEN—hematologic cancer	4.77e-06	7.7e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—AKT1—hematologic cancer	4.6e-06	7.43e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—AKT1—hematologic cancer	4.6e-06	7.43e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—EP300—hematologic cancer	4.55e-06	7.34e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—AKT1—hematologic cancer	4.27e-06	6.88e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CA—hematologic cancer	4.16e-06	6.72e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CA—hematologic cancer	3.99e-06	6.44e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CA—hematologic cancer	3.83e-06	6.18e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—AKT1—hematologic cancer	3.4e-06	5.49e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CA—hematologic cancer	3.36e-06	5.43e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—AKT1—hematologic cancer	3.26e-06	5.26e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—AKT1—hematologic cancer	3.13e-06	5.05e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—AKT1—hematologic cancer	2.75e-06	4.44e-05	CbGpPWpGaD
